BMS-986453

DRUG2 trials

Sponsors

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Susan Bal

Conditions

Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma

Phase 1

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

RecruitingNCT06153251

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyRelapsed and/or Refractory Multiple Myeloma

Start: 2024-01-23End: 2030-05-02Target: 187Updated: 2026-03-18

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

RecruitingNCT07333261

Susan BalMultiple Myeloma

Start: 2026-02-09End: 2041-12-01Target: 25Updated: 2026-02-13